APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemostats

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

Selected research

Industry Growth & Trends

Global Hemostats Industry Growth and Trends Forecast to 2032

23 December 2025116 pages

Choose your research edition.

Industry ResearchHemostats Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemostats Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Hemostats Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemostats Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemostats Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.

North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.

Read the full market overview

In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.

Report Scope

This report provides a structured, data-driven view of the global Hemostats market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hemostats market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hemostats market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hemostats.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hemostats market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hemostats Market by Company

Ethicon

Pfizer

Baxter International Inc.

C. R. Bard

The Medicines Company

Anika Therapeutics

Advanced Medical Solutions

Integra LifeSciences Corporation

B Braun Melsungen AG

Gelita Medical GmbH

Equimedical

Vascular Solutions

Marine Polymer Technologies

Z-Medica, LLC

CryoLife

BioCer Entwicklungs-GmbH.

Biom'Up SAS

Hemostats Segment by Type

Thrombin-Based Hemostats

Oxidized Regenerated Cellulose Based Hemostats

Combination Hemostats

Gelatin Based Hemostats

Collagen Based Hemostats

Hemostats Segment by Application

Prehospital Treatment

Hospital Treatment

Hemostats Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostats market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostats and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostats.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemostats manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hemostats in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Thrombin-Based Hemostats Table 2. Major Company of Oxidized Regenerated Cellulose Based Hemostats Table 3. Major Company of Combination Hemostats Table 4. Major Company of Gelatin Based Hemostats Table 5. Major Company of Collagen Based Hemostats Table 6. Global Hemostats Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Hemostats Sales by Type (2021-2026) & (K Pcs) Table 8. Global Hemostats Sales Market Share in Volume by Type (2021-2026) Table 9. Global Hemostats Sales by Type (2021-2026) & (US$ Million) Table 10. Global Hemostats Sales Market Share in Value by Type (2021-2026) Table 11. Global Hemostats Price by Type (2021-2026) & (USD/Pcs) Table 12. Global Hemostats Sales by Type (2027-2032) & (K Pcs) Table 13. Global Hemostats Sales Market Share in Volume by Type (2027-2032) Table 14. Global Hemostats Sales by Type (2027-2032) & (US$ Million) Table 15. Global Hemostats Sales Market Share in Value by Type (2027-2032) Table 16. Global Hemostats Price by Type (2027-2032) & (USD/Pcs) Table 17. North America Hemostats Sales by Type (2021-2026) & (K Pcs) Table 18. North America Hemostats Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Hemostats Sales by Type (2021-2026) & (K Pcs) Table 20. Europe Hemostats Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Hemostats Sales by Type (2021-2026) & (K Pcs) Table 22. Asia-Pacific Hemostats Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Hemostats Sales by Type (2021-2026) & (K Pcs) Table 24. Latin America Hemostats Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Hemostats Sales by Type (2021-2026) & (K Pcs) Table 26. Middle East and Africa Hemostats Sales by Type (2021-2026) & (US$ Million) Table 27. Hemostats Industry Trends Table 28. Hemostats Industry Drivers Table 29. Hemostats Industry Opportunities and Challenges Table 30. Hemostats Industry Restraints Table 31. Global Hemostats Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Hemostats Revenue Market Share by Company (2021-2026) Table 33. Global Hemostats Sales by Company (2021-2026) & (K Pcs) Table 34. Global Hemostats Sales Share by Company (2021-2026) Table 35. Global Hemostats Market Price by Company (2021-2026) & (USD/Pcs) Table 36. Global Hemostats Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Hemostats Major Company Production Sites and Headquarters Table 38. Global Hemostats Company, Product Type & Application Table 39. Global Hemostats Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Hemostats by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Hemostats Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Hemostats Sales by Region (2021-2026) & (K Pcs) Table 44. Global Hemostats Sales Market Share in Volume by Region (2021-2026) Table 45. Global Hemostats Sales by Region (2021-2026) & (US$ Million) Table 46. Global Hemostats Sales Market Share in Value by Region (2021-2026) Table 47. Global Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 48. Global Hemostats Sales by Region (2027-2032) & (K Pcs) Table 49. Global Hemostats Sales Market Share in Volume by Region (2027-2032) Table 50. Global Hemostats Sales by Region (2027-2032) & (US$ Million) Table 51. Global Hemostats Sales Market Share in Value by Region (2027-2032) Table 52. Global Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2027-2032) Table 53. Global Hemostats Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Hemostats Sales by Application (2021-2026) & (K Pcs) Table 55. Global Hemostats Sales Market Share in Volume by Application (2021-2026) Table 56. Global Hemostats Sales by Application (2021-2026) & (US$ Million) Table 57. Global Hemostats Sales Market Share in Value by Application (2021-2026) Table 58. Global Hemostats Price by Application (2021-2026) & (USD/Pcs) Table 59. Global Hemostats Sales by Application (2027-2032) & (K Pcs) Table 60. Global Hemostats Sales Market Share in Volume by Application (2027-2032) Table 61. Global Hemostats Sales by Application (2027-2032) & (US$ Million) Table 62. Global Hemostats Sales Market Share in Value by Application (2027-2032) Table 63. Global Hemostats Price by Application (2027-2032) & (USD/Pcs) Table 64. North America Hemostats Sales by Application (2021-2026) & (K Pcs) Table 65. North America Hemostats Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Hemostats Sales by Application (2021-2026) & (K Pcs) Table 67. Europe Hemostats Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Hemostats Sales by Application (2021-2026) & (K Pcs) Table 69. Asia-Pacific Hemostats Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Hemostats Sales by Application (2021-2026) & (K Pcs) Table 71. Latin America Hemostats Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Hemostats Sales by Application (2021-2026) & (K Pcs) Table 73. Middle East and Africa Hemostats Sales by Application (2021-2026) & (US$ Million) Table 74. Ethicon Company Information Table 75. Ethicon Business Overview Table 76. Ethicon Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 77. Ethicon Hemostats Product Portfolio Table 78. Ethicon Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 82. Pfizer Hemostats Product Portfolio Table 83. Pfizer Recent Development Table 84. Baxter International Inc. Company Information Table 85. Baxter International Inc. Business Overview Table 86. Baxter International Inc. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 87. Baxter International Inc. Hemostats Product Portfolio Table 88. Baxter International Inc. Recent Development Table 89. C. R. Bard Company Information Table 90. C. R. Bard Business Overview Table 91. C. R. Bard Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 92. C. R. Bard Hemostats Product Portfolio Table 93. C. R. Bard Recent Development Table 94. The Medicines Company Company Information Table 95. The Medicines Company Business Overview Table 96. The Medicines Company Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 97. The Medicines Company Hemostats Product Portfolio Table 98. The Medicines Company Recent Development Table 99. Anika Therapeutics Company Information Table 100. Anika Therapeutics Business Overview Table 101. Anika Therapeutics Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 102. Anika Therapeutics Hemostats Product Portfolio Table 103. Anika Therapeutics Recent Development Table 104. Advanced Medical Solutions Company Information Table 105. Advanced Medical Solutions Business Overview Table 106. Advanced Medical Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 107. Advanced Medical Solutions Hemostats Product Portfolio Table 108. Advanced Medical Solutions Recent Development Table 109. Integra LifeSciences Corporation Company Information Table 110. Integra LifeSciences Corporation Business Overview Table 111. Integra LifeSciences Corporation Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 112. Integra LifeSciences Corporation Hemostats Product Portfolio Table 113. Integra LifeSciences Corporation Recent Development Table 114. B Braun Melsungen AG Company Information Table 115. B Braun Melsungen AG Business Overview Table 116. B Braun Melsungen AG Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 117. B Braun Melsungen AG Hemostats Product Portfolio Table 118. B Braun Melsungen AG Recent Development Table 119. Gelita Medical GmbH Company Information Table 120. Gelita Medical GmbH Business Overview Table 121. Gelita Medical GmbH Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 122. Gelita Medical GmbH Hemostats Product Portfolio Table 123. Gelita Medical GmbH Recent Development Table 124. Equimedical Company Information Table 125. Equimedical Business Overview Table 126. Equimedical Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 127. Equimedical Hemostats Product Portfolio Table 128. Equimedical Recent Development Table 129. Vascular Solutions Company Information Table 130. Vascular Solutions Business Overview Table 131. Vascular Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 132. Vascular Solutions Hemostats Product Portfolio Table 133. Vascular Solutions Recent Development Table 134. Marine Polymer Technologies Company Information Table 135. Marine Polymer Technologies Business Overview Table 136. Marine Polymer Technologies Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 137. Marine Polymer Technologies Hemostats Product Portfolio Table 138. Marine Polymer Technologies Recent Development Table 139. Z-Medica, LLC Company Information Table 140. Z-Medica, LLC Business Overview Table 141. Z-Medica, LLC Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 142. Z-Medica, LLC Hemostats Product Portfolio Table 143. Z-Medica, LLC Recent Development Table 144. CryoLife Company Information Table 145. CryoLife Business Overview Table 146. CryoLife Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 147. CryoLife Hemostats Product Portfolio Table 148. CryoLife Recent Development Table 149. BioCer Entwicklungs-GmbH. Company Information Table 150. BioCer Entwicklungs-GmbH. Business Overview Table 151. BioCer Entwicklungs-GmbH. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 152. BioCer Entwicklungs-GmbH. Hemostats Product Portfolio Table 153. BioCer Entwicklungs-GmbH. Recent Development Table 154. Biom'Up SAS Company Information Table 155. Biom'Up SAS Business Overview Table 156. Biom'Up SAS Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 157. Biom'Up SAS Hemostats Product Portfolio Table 158. Biom'Up SAS Recent Development Table 159. North America Hemostats Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 160. North America Hemostats Sales by Country (2021-2026) & (K Pcs) Table 161. North America Hemostats Sales Market Share by Country (2021-2026) Table 162. North America Hemostats Sales Forecast by Country (2027-2032) & (K Pcs) Table 163. North America Hemostats Sales Market Share Forecast by Country (2027-2032) Table 164. North America Hemostats Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. North America Hemostats Market Size by Country (2021-2026) & (US$ Million) Table 166. North America Hemostats Market Share by Country (2021-2026) Table 167. North America Hemostats Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. North America Hemostats Market Share Forecast by Country (2027-2032) Table 169. Europe Hemostats Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 170. Europe Hemostats Sales by Country (2021-2026) & (K Pcs) Table 171. Europe Hemostats Sales Market Share by Country (2021-2026) Table 172. Europe Hemostats Sales Forecast by Country (2027-2032) & (K Pcs) Table 173. Europe Hemostats Sales Market Share Forecast by Country (2027-2032) Table 174. Europe Hemostats Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Europe Hemostats Market Size by Country (2021-2026) & (US$ Million) Table 176. Europe Hemostats Market Share by Country (2021-2026) Table 177. Europe Hemostats Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Europe Hemostats Market Share Forecast by Country (2027-2032) Table 179. Asia-Pacific Hemostats Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 180. Asia-Pacific Hemostats Sales by Country (2021-2026) & (K Pcs) Table 181. Asia-Pacific Hemostats Sales Market Share by Country (2021-2026) Table 182. Asia-Pacific Hemostats Sales Forecast by Country (2027-2032) & (K Pcs) Table 183. Asia-Pacific Hemostats Sales Market Share Forecast by Country (2027-2032) Table 184. Asia-Pacific Hemostats Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Asia-Pacific Hemostats Market Size by Country (2021-2026) & (US$ Million) Table 186. Asia-Pacific Hemostats Market Share by Country (2021-2026) Table 187. Asia-Pacific Hemostats Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Asia-Pacific Hemostats Market Share Forecast by Country (2027-2032) Table 189. Latin America Hemostats Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 190. Latin America Hemostats Sales by Country (2021-2026) & (K Pcs) Table 191. Latin America Hemostats Sales Market Share by Country (2021-2026) Table 192. Latin America Hemostats Sales Forecast by Country (2027-2032) & (K Pcs) Table 193. Latin America Hemostats Sales Market Share Forecast by Country (2027-2032) Table 194. Latin America Hemostats Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 195. Latin America Hemostats Market Size by Country (2021-2026) & (US$ Million) Table 196. Latin America Hemostats Market Share by Country (2021-2026) Table 197. Latin America Hemostats Market Size Forecast by Country (2027-2032) & (US$ Million) Table 198. Latin America Hemostats Market Share Forecast by Country (2027-2032) Table 199. Middle East and Africa Hemostats Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 200. Middle East and Africa Hemostats Sales by Country (2021-2026) & (K Pcs) Table 201. Middle East and Africa Hemostats Sales Market Share by Country (2021-2026) Table 202. Middle East and Africa Hemostats Sales Forecast by Country (2027-2032) & (K Pcs) Table 203. Middle East and Africa Hemostats Sales Market Share Forecast by Country (2027-2032) Table 204. Middle East and Africa Hemostats Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 205. Middle East and Africa Hemostats Market Size by Country (2021-2026) & (US$ Million) Table 206. Middle East and Africa Hemostats Market Share by Country (2021-2026) Table 207. Middle East and Africa Hemostats Market Size Forecast by Country (2027-2032) & (US$ Million) Table 208. Middle East and Africa Hemostats Market Share Forecast by Country (2027-2032) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Hemostats Distributors List Table 212. Hemostats Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Hemostats Image Figure 2. Global Hemostats Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemostats Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemostats Sales (2021-2032) & (K Pcs) Figure 5. Thrombin-Based Hemostats Image Figure 6. Global Thrombin-Based Hemostats Sales YoY Growth (2021-2032) & (K Pcs) Figure 7. Oxidized Regenerated Cellulose Based Hemostats Image Figure 8. Global Oxidized Regenerated Cellulose Based Hemostats Sales YoY Growth (2021-2032) & (K Pcs) Figure 9. Combination Hemostats Image Figure 10. Global Combination Hemostats Sales YoY Growth (2021-2032) & (K Pcs) Figure 11. Gelatin Based Hemostats Image Figure 12. Global Gelatin Based Hemostats Sales YoY Growth (2021-2032) & (K Pcs) Figure 13. Collagen Based Hemostats Image Figure 14. Global Collagen Based Hemostats Sales YoY Growth (2021-2032) & (K Pcs) Figure 15. Global Hemostats Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Hemostats Market Share by Type 2025 VS 2032 Figure 17. North America Hemostats Sales Market Share in Volume by Type in 2025 Figure 18. North America Hemostats Sales Market Share in Value by Type in 2025 Figure 19. Europe Hemostats Sales Market Share in Volume by Type in 2025 Figure 20. Europe Hemostats Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Hemostats Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Hemostats Sales Market Share in Value by Type in 2025 Figure 23. Latin America Hemostats Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Hemostats Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Hemostats Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Hemostats Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Hemostats Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Prehospital Treatment Image Figure 30. Global Prehospital Treatment Sales YoY Growth (2021-2032) & (K Pcs) Figure 31. Hospital Treatment Image Figure 32. Global Hospital Treatment Sales YoY Growth (2021-2032) & (K Pcs) Figure 33. Global Hemostats Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Hemostats Market Share by Application 2025 VS 2032 Figure 35. North America Hemostats Sales Market Share in Volume by Application in 2025 Figure 36. North America Hemostats Sales Market Share in Value by Application in 2025 Figure 37. Europe Hemostats Sales Market Share in Volume by Application in 2025 Figure 38. Europe Hemostats Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Hemostats Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Hemostats Sales Market Share in Value by Application in 2025 Figure 41. Latin America Hemostats Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Hemostats Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Hemostats Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Hemostats Sales Market Share in Value by Application in 2025 Figure 45. North America Hemostats Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 46. North America Hemostats Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Hemostats Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Hemostats Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Hemostats Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 50. Europe Hemostats Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Hemostats Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Hemostats Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Hemostats Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 54. Asia-Pacific Hemostats Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Hemostats Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Hemostats Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Hemostats Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 58. Latin America Hemostats Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Hemostats Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Hemostats Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Hemostats Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 62. Middle East and Africa Hemostats Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Hemostats Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Hemostats Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Hemostats Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Hemostats Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Thrombin-Based Hemostats
  • Oxidized Regenerated Cellulose Based Hemostats
  • Combination Hemostats
  • Gelatin Based Hemostats
  • Collagen Based Hemostats
Applications
  • Prehospital Treatment
  • Hospital Treatment
Companies covered
  • Ethicon
  • Pfizer
  • Baxter International Inc.
  • C. R. Bard
  • The Medicines Company
  • Anika Therapeutics
  • Advanced Medical Solutions
  • Integra LifeSciences Corporation
  • B Braun Melsungen AG
  • Gelita Medical GmbH
  • Equimedical
  • Vascular Solutions
  • Marine Polymer Technologies
  • Z-Medica, LLC
  • CryoLife
  • BioCer Entwicklungs-GmbH.
  • Biom'Up SAS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hemostats Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hemostats Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hemostats Market by Type
  6. 1.3.1 Thrombin-Based Hemostats
  7. 1.3.2 Oxidized Regenerated Cellulose Based Hemostats
  8. 1.3.3 Combination Hemostats
  9. 1.3.4 Gelatin Based Hemostats
  10. 1.3.5 Collagen Based Hemostats
  11. 1.4 Global Hemostats Market Size by Type
  12. 1.4.1 Global Hemostats Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Hemostats Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Hemostats Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Hemostats Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Hemostats Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Hemostats Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Hemostats Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Hemostats Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hemostats Industry Trends
  2. 2.2 Hemostats Industry Drivers
  3. 2.3 Hemostats Industry Opportunities and Challenges
  4. 2.4 Hemostats Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hemostats Revenue (2021-2026)
  2. 3.2 Global Top Players by Hemostats Sales (2021-2026)
  3. 3.3 Global Top Players by Hemostats Price (2021-2026)
  4. 3.4 Global Hemostats Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemostats Major Company Production Sites & Headquarters
  6. 3.6 Global Hemostats Company, Product Type & Application
  7. 3.7 Global Hemostats Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemostats Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemostats Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemostats Tier 1, Tier 2, and Tier 3
4 Hemostats Regional Status and Outlook
  1. 4.1 Global Hemostats Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hemostats Historic Market Size by Region
  3. 4.2.1 Global Hemostats Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hemostats Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hemostats Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hemostats Forecasted Market Size by Region
  7. 4.3.1 Global Hemostats Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hemostats Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hemostats Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hemostats by Application
  1. 5.1 Hemostats Market by Application
  2. 5.1.1 Prehospital Treatment
  3. 5.1.2 Hospital Treatment
  4. 5.2 Global Hemostats Market Size by Application
  5. 5.2.1 Global Hemostats Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Hemostats Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Hemostats Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Hemostats Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Hemostats Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Hemostats Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Hemostats Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Hemostats Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ethicon
  2. 6.1.1 Ethicon Company Information
  3. 6.1.2 Ethicon Business Overview
  4. 6.1.3 Ethicon Hemostats Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ethicon Hemostats Product Portfolio
  6. 6.1.5 Ethicon Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Hemostats Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Hemostats Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Baxter International Inc.
  14. 6.3.1 Baxter International Inc. Company Information
  15. 6.3.2 Baxter International Inc. Business Overview
  16. 6.3.3 Baxter International Inc. Hemostats Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Baxter International Inc. Hemostats Product Portfolio
  18. 6.3.5 Baxter International Inc. Recent Developments
  19. 6.4 C. R. Bard
  20. 6.4.1 C. R. Bard Company Information
  21. 6.4.2 C. R. Bard Business Overview
  22. 6.4.3 C. R. Bard Hemostats Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 C. R. Bard Hemostats Product Portfolio
  24. 6.4.5 C. R. Bard Recent Developments
  25. 6.5 The Medicines Company
  26. 6.5.1 The Medicines Company Company Information
  27. 6.5.2 The Medicines Company Business Overview
  28. 6.5.3 The Medicines Company Hemostats Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 The Medicines Company Hemostats Product Portfolio
  30. 6.5.5 The Medicines Company Recent Developments
  31. 6.6 Anika Therapeutics
  32. 6.6.1 Anika Therapeutics Company Information
  33. 6.6.2 Anika Therapeutics Business Overview
  34. 6.6.3 Anika Therapeutics Hemostats Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Anika Therapeutics Hemostats Product Portfolio
  36. 6.6.5 Anika Therapeutics Recent Developments
  37. 6.7 Advanced Medical Solutions
  38. 6.7.1 Advanced Medical Solutions Company Information
  39. 6.7.2 Advanced Medical Solutions Business Overview
  40. 6.7.3 Advanced Medical Solutions Hemostats Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Advanced Medical Solutions Hemostats Product Portfolio
  42. 6.7.5 Advanced Medical Solutions Recent Developments
  43. 6.8 Integra LifeSciences Corporation
  44. 6.8.1 Integra LifeSciences Corporation Company Information
  45. 6.8.2 Integra LifeSciences Corporation Business Overview
  46. 6.8.3 Integra LifeSciences Corporation Hemostats Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Integra LifeSciences Corporation Hemostats Product Portfolio
  48. 6.8.5 Integra LifeSciences Corporation Recent Developments
  49. 6.9 B Braun Melsungen AG
  50. 6.9.1 B Braun Melsungen AG Company Information
  51. 6.9.2 B Braun Melsungen AG Business Overview
  52. 6.9.3 B Braun Melsungen AG Hemostats Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 B Braun Melsungen AG Hemostats Product Portfolio
  54. 6.9.5 B Braun Melsungen AG Recent Developments
  55. 6.10 Gelita Medical GmbH
  56. 6.10.1 Gelita Medical GmbH Company Information
  57. 6.10.2 Gelita Medical GmbH Business Overview
  58. 6.10.3 Gelita Medical GmbH Hemostats Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Gelita Medical GmbH Hemostats Product Portfolio
  60. 6.10.5 Gelita Medical GmbH Recent Developments
  61. 6.11 Equimedical
  62. 6.11.1 Equimedical Company Information
  63. 6.11.2 Equimedical Business Overview
  64. 6.11.3 Equimedical Hemostats Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Equimedical Hemostats Product Portfolio
  66. 6.11.5 Equimedical Recent Developments
  67. 6.12 Vascular Solutions
  68. 6.12.1 Vascular Solutions Company Information
  69. 6.12.2 Vascular Solutions Business Overview
  70. 6.12.3 Vascular Solutions Hemostats Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Vascular Solutions Hemostats Product Portfolio
  72. 6.12.5 Vascular Solutions Recent Developments
  73. 6.13 Marine Polymer Technologies
  74. 6.13.1 Marine Polymer Technologies Company Information
  75. 6.13.2 Marine Polymer Technologies Business Overview
  76. 6.13.3 Marine Polymer Technologies Hemostats Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Marine Polymer Technologies Hemostats Product Portfolio
  78. 6.13.5 Marine Polymer Technologies Recent Developments
  79. 6.14 Z-Medica, LLC
  80. 6.14.1 Z-Medica, LLC Company Information
  81. 6.14.2 Z-Medica, LLC Business Overview
  82. 6.14.3 Z-Medica, LLC Hemostats Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Z-Medica, LLC Hemostats Product Portfolio
  84. 6.14.5 Z-Medica, LLC Recent Developments
  85. 6.15 CryoLife
  86. 6.15.1 CryoLife Company Information
  87. 6.15.2 CryoLife Business Overview
  88. 6.15.3 CryoLife Hemostats Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 CryoLife Hemostats Product Portfolio
  90. 6.15.5 CryoLife Recent Developments
  91. 6.16 BioCer Entwicklungs-GmbH.
  92. 6.16.1 BioCer Entwicklungs-GmbH. Company Information
  93. 6.16.2 BioCer Entwicklungs-GmbH. Business Overview
  94. 6.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 BioCer Entwicklungs-GmbH. Hemostats Product Portfolio
  96. 6.16.5 BioCer Entwicklungs-GmbH. Recent Developments
  97. 6.17 Biom'Up SAS
  98. 6.17.1 Biom'Up SAS Company Information
  99. 6.17.2 Biom'Up SAS Business Overview
  100. 6.17.3 Biom'Up SAS Hemostats Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Biom'Up SAS Hemostats Product Portfolio
  102. 6.17.5 Biom'Up SAS Recent Developments
7 North America by Country
  1. 7.1 North America Hemostats Sales by Country
  2. 7.1.1 North America Hemostats Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hemostats Sales by Country (2021-2026)
  4. 7.1.3 North America Hemostats Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hemostats Market Size by Country
  6. 7.2.1 North America Hemostats Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hemostats Market Size by Country (2021-2026)
  8. 7.2.3 North America Hemostats Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hemostats Sales by Country
  2. 8.1.1 Europe Hemostats Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hemostats Sales by Country (2021-2026)
  4. 8.1.3 Europe Hemostats Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hemostats Market Size by Country
  6. 8.2.1 Europe Hemostats Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hemostats Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hemostats Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hemostats Sales by Country
  2. 9.1.1 Asia-Pacific Hemostats Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hemostats Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hemostats Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hemostats Market Size by Country
  6. 9.2.1 Asia-Pacific Hemostats Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hemostats Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hemostats Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hemostats Sales by Country
  2. 10.1.1 South America Hemostats Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hemostats Sales by Country (2021-2026)
  4. 10.1.3 South America Hemostats Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hemostats Market Size by Country
  6. 10.2.1 South America Hemostats Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hemostats Market Size by Country (2021-2026)
  8. 10.2.3 South America Hemostats Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hemostats Sales by Country
  2. 11.1.1 Middle East and Africa Hemostats Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hemostats Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hemostats Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hemostats Market Size by Country
  6. 11.2.1 Middle East and Africa Hemostats Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hemostats Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hemostats Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hemostats Value Chain Analysis
  2. 12.1.1 Hemostats Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hemostats Production Mode & Process
  7. 12.2 Hemostats Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hemostats Distributors
  10. 12.2.3 Hemostats Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst